Agios Pharmaceuticals (AGIO) Operating Margin Growth (5y) (2017 - 2025)

Agios Pharmaceuticals (AGIO) Operating Margin Growth (5y) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Agios Pharmaceuticals 2.13 Bn 2.13 Bn 19.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -39,903.00
Sep 30, 2025 -67,602.00
Jun 30, 2025 -79,717.00
Mar 31, 2025 -112,205.00
Dec 31, 2024 -86,641.00
Sep 30, 2024 -72,786.00
Jun 30, 2024 -79,405.00
Mar 31, 2024 -80,183.00
Dec 31, 2023 -117,518.00
Sep 30, 2023 -71,119.00
Jun 30, 2023 -121,550.00
Mar 31, 2023 -54,254.00
Dec 31, 2022 -138,119.00
Sep 30, 2022 -189,503.00
Dec 31, 2020 32,826.00
Sep 30, 2020 50,725.00
Jun 30, 2020 2,013.00
Mar 31, 2020 194.00
Dec 31, 2019 -11,629.00
Sep 30, 2019 -42,854.00